Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study

被引:0
|
作者
M. Toeller
A. Buyken
G. Heitkamp
S. Brämswig
J. Mann
R. Milne
F. A. Gries
H. Keen
机构
[1] Diabetes Research Institute at the Heinrich-Heine-University,
[2] Clinical Department,undefined
[3] Düsseldorf,undefined
[4] Germany,undefined
[5] University of Otago,undefined
[6] Department of Nutrition,undefined
[7] Dunedin,undefined
[8] New Zealand,undefined
[9] Unit for Metabolic Medicine,undefined
[10] United Medical and Dental Schools,undefined
[11] Guy's Hospital Campus,undefined
[12] London,undefined
[13] UK,undefined
来源
Diabetologia | 1997年 / 40卷
关键词
Keywords Insulin-dependent diabetes mellitus; protein intake; urinary albumin excretion rate; diabetic nephropathy; diet recommendations; Europe.;
D O I
暂无
中图分类号
学科分类号
摘要
For people with insulin-dependent diabetes mellitus (IDDM) renal disease represents a life-threatening and costly complication. The EURODIAB IDDM Complications Study, a cross-sectional, clinic-based study, was designed to determine the prevalence of renal complications and putative risk factors in stratified samples of European individuals with IDDM. The present study examined the relationship between dietary protein intake and urinary albumin excretion rate (AER). Food intake was assessed centrally by a standardized 3-day dietary record. Urinary AER was determined in a central laboratory from a timed 24-h urine collection. Complete data were available from 2696 persons with IDDM from 30 centres in 16 European countries. In individuals who reported protein consumption less than 20 % of total food energy intake, mean AER was below 20 μg/min. In those in whom protein intake constituted more than 20 %, mean AER increased, a trend particularly pronounced in individuals with hypertension and/or poor metabolic control. Trends reached statistical significance for intakes of total protein (% of energy, p = 0.01) and animal protein (% of energy, p = 0.02), while no association was seen for vegetable protein (p = 0.83). These findings support the current recommendation for people with diabetes not to exceed a protein intake of 20 % of total energy. Monitoring and adjustment of dietary protein appears particularly desirable for individuals with AER exceeding 20 μg/min (approximately 30 mg/24 h), especially when arterial pressure is raised and/or diabetic control is poor. [Diabetologia (1997) 40: 1219–1226]
引用
收藏
页码:1219 / 1226
页数:7
相关论文
共 50 条
  • [31] URINARY ALBUMIN EXCRETION RATES IN NORMAL AND HYPERTENSIVE PREGNANCY
    BROWN, MA
    WANG, MX
    BUDDLE, ML
    CARLTON, MA
    CARIO, GM
    WHITWORTH, JA
    KIDNEY INTERNATIONAL, 1994, 45 (04) : 1269 - 1269
  • [32] The effect of distance from health care centre on complication rates in the EURODIAB IDDM study
    Holloway, J
    Fuller, JH
    DIABETOLOGIA, 1997, 40 : 2383 - 2383
  • [33] Serum lipid values and central obesity in type 1 diabetes - The eurodiab IDDM complications study
    Idzior-Walus, B
    Stevens, L
    Sieradzki, J
    Fuller, JH
    DIABETOLOGIA, 1999, 42 : A285 - A285
  • [34] Metabolic syndrome and nephropathy in type 1 diabetes: The Italian cohort of the EURODIAB IDDM complications study
    Penno, G
    Miccoli, R
    Pucci, L
    Lucchesi, D
    Bandinelli, S
    Fotino, C
    Triscornia, S
    Bianchi, C
    Del Prato, S
    Santeusanio, F
    Fuller, J
    DIABETES, 2005, 54 : A211 - A211
  • [35] Metabolic syndrome and nephropathy in type 1 diabetes: the Italian cohort of the Eurodiab IDDM Complications Study
    Penno, G
    Miccoli, R
    Pucci, L
    Lucchesi, D
    Bandinelli, S
    Fotino, C
    Triscornia, S
    Bianchi, C
    Santeusanio, F
    Reboldi, P
    Fuller, J
    Del Prato, S
    DIABETOLOGIA, 2005, 48 : A373 - A373
  • [36] Diastolic function and arterial compliance are related to duration of IDDM and urinary albumin excretion.
    Snorgaard, O
    Faber, J
    Wiinberg, N
    Mehlsen, J
    Jakobsen, TJ
    Hildebrandt, P
    DIABETOLOGIA, 1997, 40 : 1798 - 1798
  • [37] ABNORMAL INCREASES IN URINARY ALBUMIN EXCRETION DURING PREGNANCY IN IDDM WOMEN WITH PREEXISTING MICROALBUMINURIA
    BIESENBACH, G
    ZAZGORNIK, J
    STOGER, H
    GRAFINGER, P
    HUBMANN, R
    KAISER, W
    JANKO, O
    STUBY, U
    DIABETOLOGIA, 1994, 37 (09) : 905 - 910
  • [38] Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe: the EURODIAB IDDM complications study
    Collado-Mesa, F
    Colhoun, HM
    Stevens, LK
    Boavida, J
    Ferriss, JB
    Karamanos, B
    Kempler, P
    Michel, G
    Roglic, G
    Fuller, JH
    DIABETIC MEDICINE, 1999, 16 (01) : 41 - 48
  • [39] Protein intake in relation to risk of hypertension and microalbuminuria in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
    Altorf-van der Kuil, Wieke
    Engberink, Marielle F.
    IJpma, Irene
    Verberne, Lisa D. M.
    Toeller, Monika
    Chaturvedi, Nish
    Fuller, John H.
    Soedamah-Muthu, Sabita S.
    JOURNAL OF HYPERTENSION, 2013, 31 (06) : 1151 - 1159
  • [40] The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group
    Veglio, M
    Borra, M
    Stevens, LK
    Fuller, JH
    Perin, PC
    DIABETOLOGIA, 1999, 42 (01) : 68 - 75